India-bred private equity firm ChrysCapital is investing $350 million in Mankind Pharmaceuticals for a 10% stake..Shardul Amarchand Mangaldas acted for ChrysCapital and the team was led by Partner Gunjan Shah, Shruti Kinra, Arjun Ghose along with Senior Associate Sneha Vardhan and Associates Rahil Edward Pereira, Sangamitra Sankaraiah, Aditi Kapoor, Shubhaang Sinha, and Karthik SD.Partner Aparna Mehra along with Principal Associate Rohan Arora and Associate Neetu Ahlawat advised on competition law aspect..Khaitan & Co advised Mankind Pharma and the team was led by Partner Bharat Anand..This deal marks Chrys Capital’s return to Mankind Pharma, a company it helped build – in 2015. It had sold 11 percent stake in Mankind to Capital International for $214 million, reported Business Standard.
India-bred private equity firm ChrysCapital is investing $350 million in Mankind Pharmaceuticals for a 10% stake..Shardul Amarchand Mangaldas acted for ChrysCapital and the team was led by Partner Gunjan Shah, Shruti Kinra, Arjun Ghose along with Senior Associate Sneha Vardhan and Associates Rahil Edward Pereira, Sangamitra Sankaraiah, Aditi Kapoor, Shubhaang Sinha, and Karthik SD.Partner Aparna Mehra along with Principal Associate Rohan Arora and Associate Neetu Ahlawat advised on competition law aspect..Khaitan & Co advised Mankind Pharma and the team was led by Partner Bharat Anand..This deal marks Chrys Capital’s return to Mankind Pharma, a company it helped build – in 2015. It had sold 11 percent stake in Mankind to Capital International for $214 million, reported Business Standard.
